Endpoint Clinical Launches Elosity R3 AI Trial Platform
Raleigh, North Carolina | April 13, 2026 Endpoint Clinical has announced the release of Elosity® R3, a major upgrade...
GCP compliance
Advertisement
Fortrea Launches AI-Powered FIT Platform to Transform Clinical Trials
DURHAM, N.C., April 7, 2026 Fortrea has launched its advanced AI-powered platform, Fortrea Intelligent Technology™ (FIT), aimed at transforming...
FDA Approves J&J’s ICOTYDE Oral Peptide for Psoriasis
SPRING HOUSE, Pennsylvania, USA – March 18, 2026 In a major advancement for dermatology and systemic therapies, Johnson &...
ICON Accellacare Expands Oncology Trial Capacity in U.S.
DUBLIN, IRELAND | January 27, 2026 — ICON plc, a global clinical research organization, announced a significant expansion of...
Evestia Clinical Expands Global CRO Platform With ICRC-Weyer
LONDON, UNITED KINGDOM | January 27, 2026 — Evestia Clinical, a leading independent global specialist Contract Research Organization (CRO),...
Advertisements
Mayo Clinic Advances Translational Oncology Clinical Trials
ROCHESTER, MINNESOTA & PHOENIX, ARIZONA | January 22, 2026 — The Advanced Clinical Trials and Translational Sciences Research Program...
Cardiol Reaches 50% Enrollment in Phase III MAVERIC Trial
Toronto, Jan. 13, 2026 — Cardiol Therapeutics Inc. announced that it has surpassed the 50% patient enrollment milestone in...
SafeHeal Launches Pivotal SAFE-3CV IDE Study for Colovac
Paris and Tampa, Fla., Jan. 13, 2026 — SafeHeal®, a clinical-stage medical device innovator in colorectal surgery, announced the...
Delcath Reports Phase 3 Subgroup Outcomes in Uveal Melanoma
QUEENSBURY, NEW YORK | December 31, 2025 — Delcath Systems announced the peer-reviewed publication of prespecified subgroup analyses from...
MedMira Advances Rapid Diagnostics With Health Canada Approval
HALIFAX, NOVA SCOTIA | December 30, 2025 — MedMira Inc. reported its first-quarter FY2026 results, highlighting a pivotal period...
Advertisement
